Trial intelligence / Profile preview

Parecoxib Q12h vs SOS regimen for bowel function recovery after colorectal surgery

ChiCTR2000041184Phase 4Completed

Sponsor
The First Affiliated Hospital of Harbin Medical University
Start
May 2017
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of parecoxib in postoperative recovery (2 arms), sponsored by The First Affiliated Hospital of Harbin Medical University. Primary endpoint: Recovery of bowel function. Started May 2017; status: completed.

02

Drugs

parecoxib
03

Conditions

postoperative recovery

Beyond the preview

Go deeper on ChiCTR2000041184.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2000041184.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call